Market Closed - OTC Markets 11:31:49 2021-08-09 EDT 5-day change 1st Jan Change
0.000100 USD -.--% Intraday chart for DiaSys Corporation -.--% -

Valuation: DiaSys Corporation

Market Cap 51.44K 45.2K 42.19K 38.72K 72.49K 4.93M 74.27K 500K 196K 2.44M 193K 189K 8.43M P/E 2006
-3.78x
P/E 2007 -3x
Enterprise Value 646K 567K 530K 486K 910K 61.86M 932K 6.28M 2.46M 30.61M 2.42M 2.37M 106M EV / Sales 2006
2.7x
EV / Sales 2007 2.04x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0
10 years 0
Extreme 0
0
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
+0.01%+9.50%+19.56%+2.60% 214B
-1.29%+9.69%-5.01%-24.45% 140B
-2.40%+3.64%-28.94%+8.14% 128B
-0.04%+7.14%-56.76%-10.93% 68.46B
+2.49%+1.65%+6.57%+2.41% 48.18B
+4.51%+8.59%-22.65%-28.66% 45.56B
-0.17%+5.13%+17.07%+11.31% 39.69B
-1.15%+2.34%+25.16%+32.79% 37.69B
+2.55%+11.08%-22.83%-3.98% 30.14B
Average +0.42%+5.80%-7.53%-1.20% 75.17B
Weighted average by Cap. -0.20%+7.26%-5.15%-2.92%

Financials

2006 2007
Net sales 1.69M 1.48M 1.38M 1.27M 2.38M 162M 2.44M 16.42M 6.42M 80.01M 6.34M 6.2M 277M 1.68M 1.47M 1.38M 1.26M 2.36M 161M 2.42M 16.32M 6.38M 79.54M 6.3M 6.16M 275M
Net income -1.05M -921K -859K -789K -1.48M -100M -1.51M -10.19M -3.99M -49.66M -3.93M -3.85M -172M -785K -690K -644K -591K -1.11M -75.21M -1.13M -7.64M -2.99M -37.22M -2.95M -2.88M -129M
Net Debt 302K 265K 248K 227K 426K 28.93M 436K 2.94M 1.15M 14.31M 1.13M 1.11M 49.48M 594K 522K 488K 447K 838K 56.93M 858K 5.78M 2.26M 28.17M 2.23M 2.18M 97.39M
Logo DiaSys Corporation
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
Employees
10
  1. Stock Market
  2. Stocks
  3. DYXC Stock